Single-tablet HIV Treatment Shows Better Outcomes Over Multi-tablet Regimen | Latest News RSS feed

Single-tablet HIV Treatment Shows Better Outcomes Over Multi-tablet Regimen - Latest News


Single-tablet HIV treatment shows better outcomes over multi-tablet regimen

Taking one tablet per day, versus multiple tablets, appears to result in better outcomes for HIV patients. Credit: Mitch Mirkin HIV patients on a single-tablet daily regimen had better treatment reten... read more

Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA® Shows Positive Outcome in Treatment of Antiretroviral-Naïve HIV Patients

Findings from the study demonstrated that the single tablet regimen (STR) D/C/F/TAF provided ... and safety of D/C/F/TAF versus the control in HIV-1 positive treatment-naïve adult patients over 48 wee... read more

Medicaid policy may deny access to HIV medication

The U.S. Department of Health and Human Services raised concerns about the safety of Atripla over ... single-tablet regimens are where HIV treatment is headed, and having these regimens instead of pat... read more

Looking for another news?


Gilead Sciences' CEO Presents at The 30th Annual JPMorgan Chase Healthcare Conference (Transcript)

Gilead Sciences, Inc. (NASDAQ:GILD) The 30th Annual JPMorgan Chase Healthcare Conference ... the treatment of HIV. We partnered with Bristol-Myers and Merck with their efavirenz to combine it with Tru... read more

Jetpack

Gilead Sciences' (GILD) Management Presents at Cowen & Company 35th Annual Health Care Conference (Transcript)

These single-tablet regimens are proven to be very popular with patients and they really do help to increase adherence and therefore better patient outcomes ... in HIV-HCV co-infected patients with ge... read more

Gilead Sciences Management Discusses Q3 2012 Results - Earnings Call Transcript

Total utilization of single tablet regimens for naive patients was boosted by Eviplera to a new high of nearly 30%. Eviplera is now the #2 regimen in HIV naive patients ... depending on the outcome. I... read more

HIV Treatment Adds Safe Once-a-Day Pill

But the findings are still beneficial, as evidence shows people who receive treatment for HIV do better with single-tablet, once-daily dosing ... Ultimately, the regimen can improve a patient's outcom... read more

Better outcomes for patients using single-pill combination for blood pressure

People who are prescribed a combination pill to manage their high blood pressure are more likely to take their medicine as instructed and have better health outcomes than ... saving one in 40 lives ov... read more

ProfNet Experts Available on ACA Reform, Veterans and PTSD, More

The Loan bears... at 17:31 Janssen Announces U.S. FDA Approval of SYMTUZAtm (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection The Jans... read more

TO HEPATITIS C TREATMENT

Suggested citation. Progress report on access to hepatitis C treatment: focus on overcoming barriers in low- and middle-income countries, March 2018. Geneva, Switzerland: World Health Organization; 20... read more

Gilead Beats on Q3 Earnings, Sovaldi Sales Fall Sequentially

Other anti-viral products, such as HIV treatments Complera/Eviplera ... physicians and patients wait for Harvoni, an oral single tablet regimen for HCV. Harvoni is priced at $94,500 for a 12-week trea... read more

Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA® Shows Positive Outcome in Treatment of Antiretroviral-Naïve HIV Patients

MILAN--(BUSINESSWIRE)-- Once-daily single tablet complete regimen demonstrates effective viral suppression in HIV-1 patients, providing a genetic barrier to the development of resistance with a favour... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us